Net profit of Emcure Pharmaceuticals rose 49.97% to Rs 230.54 crore in the quarter ended December 2025 as against Rs 153.72 crore during the previous quarter ended December 2024. Sales rose 20.42% to Rs 2363.48 crore in the quarter ended December 2025 as against Rs 1962.63 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 2363.48 | 1962.63 | 20 |
| OPM % | 20.85 | 18.07 | - |
| PBDT | 456.62 | 326.73 | 40 |
| PBT | 351.94 | 229.92 | 53 |
| NP | 230.54 | 153.72 | 50 |